Exendin-4 reduces glycemia by increasing liver glucokinase activity: an insulin independent effect.

Journal Title: Pharmacological Reports - Year 2012, Vol 64, Issue 1

Abstract

Exendin-4 is a stable peptide agonist of GLP-1 receptor that exhibits insulinotropic actions. Some in vivo studies indicated insulin-independent glucoregulatory actions of exendin-4. That finding prompted us to evaluate effects of exendin-4 on liver glucose metabolism. Acute and chronic treatment of exendin-4 resulted in increased hepatic glucokinase activity in db/db mice but not in lean C57 mice. The stimulatory effect of exendin-4 on glucokinase activity was abrogated by exendin 9-39, a GLP-1 antagonist. Exposure of hepatocytes isolated from db/db mice to exendin-4 elicited a rapid increase in cAMP, which was synergized by IBMX, an inhibitor of cAMP degradation. The GLP-1 antagonist, exendin 9-39, has abolished the cAMP generating effects of exendin-4 as well. Furthermore, chronic treatment of exendin-4 in streptozotocin-treated C57 mice resulted in restoration of hepatic glycogen, an indicator of improved glucose metabolism, without apparent changes in serum insulin levels. In conclusion, exendin-4 increased glucokinase enzyme protein and activity in liver via a mechanism parallel to and independent of insulin. Exendin-4-induced increase in hepatic glucokinase activity is more pronounced in the presence of hepatic insulin resistance. This beneficial effect of exendin-4 on liver glucokinase activity may be mediated by GLP-1 receptor.

Authors and Affiliations

Nirav Dhanesha, Amit Joharapurkar, Gaurang Shah, Vipin Dhote, Samadhan Kshirsagar, Rajesh Bahekar, Mukul Jain

Keywords

Related Articles

No association of three GRIN2B polymorphisms with lithium response in bipolar patients.

We investigated three polymorphisms in the NMDA receptor 2B subunit gene (GRIN2B) as a candidate gene for lithium response involved in glutamatergic neurotransmission. One hundred five bipolar patients treated with lithi...

Flowers for Algernon: steroid dysgenesis, epigenetics and brain disorders.

While a recent study has reported that early citalopram exposure alters cortical network function and produces autistic-like behaviors in male rats, when evaluating antidepressant animal models of autism spectrum disorde...

Novel variant of CYP2D6*6 is undetected by a commonly used genotyping procedure.

We report the identification of a novel and defective variant of the gene encoding cytochrome P450 2D6 (CYP2D6). This novel variant is a subtype of CYP2D6*6 that was undetected by a commercially available 5' exonuclease-...

Effects of the noradrenergic neurotoxin DSP-4 on the expression of α(1)-adrenoceptor subtypes after antidepressant treatment.

We have previously reported that chronic imipramine and electroconvulsive treatments increase the α(1A)-adrenoceptor (but not the α(1B) subtype) mRNA level and the receptor density in the rat cerebral cortex. Furthermore...

Effect of thymoquinone on the lung pathology and cytokine levels of ovalbumin-sensitized guinea pigs.

Different pharmacological effects from Nigella sativa have been demonstrated in guinea pig tracheal chains in previous studies. In the present study, the prophylactic effects of thymoquinone on lung pathology as well as...

Download PDF file
  • EP ID EP130055
  • DOI -
  • Views 78
  • Downloads 0

How To Cite

Nirav Dhanesha, Amit Joharapurkar, Gaurang Shah, Vipin Dhote, Samadhan Kshirsagar, Rajesh Bahekar, Mukul Jain (2012). Exendin-4 reduces glycemia by increasing liver glucokinase activity: an insulin independent effect.. Pharmacological Reports, 64(1), 140-149. https://europub.co.uk/articles/-A-130055